Patents by Inventor Matthew ONG

Matthew ONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220288294
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: May 25, 2022
    Publication date: September 15, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220265913
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: May 5, 2022
    Publication date: August 25, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220054728
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220054727
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220054726
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20220054725
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • System and method for removal of immune inhibitors from biological fluids
    Patent number: 11123467
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: September 21, 2021
    Assignee: IMMUNICOM, INC.
    Inventors: Steven Josephs, Matthew Ong, Amir Jafri, Robert Segal, Stephen Prince
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20210146029
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: November 19, 2019
    Publication date: May 20, 2021
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE
  • SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
    Publication number: 20210146030
    Abstract: The present system and method are useful for the removal of immune inhibitors such as soluble TNF receptors from the body fluid of cancer patients. In some embodiments, soluble TNF-Receptors 1 and 2 are selectively removed from plasma at 80% or more efficiency. In some embodiments, the system includes an immobilized capture ligand of a single chain TNF?. The system and method are useful for the treatment of different cancer types, stages and severity.
    Type: Application
    Filed: October 1, 2020
    Publication date: May 20, 2021
    Inventors: Steven JOSEPHS, Matthew ONG, Amir JAFRI, Robert SEGAL, Stephen PRINCE